or
forgot password
  • cancer clinical trials in kentucky

  • GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
    GSK Investigational Site
    Lexington, Kentucky 40536-0098
    Lung Cancer, Non-Small Cell
    A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
    University of Kentucky Medical Center

    Trial Locations
    University of Kentucky Medical Center
    NortonHealtcare Inc.
    Invasive Breast Cancer
    ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
    GSK Investigational Site
    Lexington, Kentucky 40536-0098
    Neoplasms, Breast, Breast Cancer
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    Saint Elizabeth Medical Center South

    Trial Locations
    Saint Elizabeth Medical Center South
    University of Kentucky
    Endometrial Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Doctors Carrol, Sheth, Raghavan
    Louisville, Kentucky 40215
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer
    Kentuckiana Cancer Institute, PLLC
    Louisville, Kentucky 40202
    Breast Cancer
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    Lucille P. Markey Cancer Center at University of Kentucky

    Trial Locations
    Lucille P. Markey Cancer Center at University of Kentucky
    Kosair Children's Hospital
    Neuroblastoma
    Randomized Phase 3b Study in Previously Untreated Multiple Myeloma Patients: VELCADE,Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone
    Western Kentucky Hematology and Oncology Group

    Trial Locations
    Western Kentucky Hematology and Oncology Group
    Kentucky Cancer Clinic
    Multiple Myeloma
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    Central Baptist Hospital

    Trial Locations
    Central Baptist Hospital
    The James Graham Brown Cancer Center at University of Louisville
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma
    University of Kentucky College of Medicine

    Trial Locations
    University of Kentucky College of Medicine
    Montgomery Cancer Center
    Multiple Myeloma
    Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Lung Cancer
    Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia
    Lucille P. Markey Cancer Center at University of Kentucky

    Trial Locations
    Lucille P. Markey Cancer Center at University of Kentucky
    Kosair Children's Hospital
    Leukemia
    Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    Lucille P. Markey Cancer Center at University of Kentucky

    Trial Locations
    Lucille P. Markey Cancer Center at University of Kentucky
    Kosair Children's Hospital
    Leukemia
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Norton Suburban Hospital
    Louisville, Kentucky 40207
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
    Lucille P. Markey Cancer Center at University of Kentucky

    Trial Locations
    Lucille P. Markey Cancer Center at University of Kentucky
    Kosair Children's Hospital
    Neuroblastoma
    Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
    Pfizer Investigational Site
    Crestview Hills, Kentucky 41017
    Chronic Myeloid Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Our Lady Bellefonte Hospital

    Trial Locations
    Our Lady Bellefonte Hospital
    University of Kentucky
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Early Detection of Lung Cancer in a High-Risk Population Defined by PFT, Biomarkers, and CT Scanning
    St. Claire Regional Medical Center

    Trial Locations
    St. Claire Regional Medical Center
    Highlands Regional Medical Center
    Lake Cumberland Regional Hospital
    Lung Cancer
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Doctors Carrol, Sheth, Raghavan
    Louisville, Kentucky 40215
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Doctors Carrol, Sheth, Raghavan

    Trial Locations
    Doctors Carrol, Sheth, Raghavan
    Owensboro Mercy Medical Center
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
    Baptist Hospital East

    Trial Locations
    Baptist Hospital East
    Norton Cancer Institute
    Non-Small Cell Lung Cancer
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    University of Kentucky Medical Center

    Trial Locations
    University of Kentucky Medical Center
    NortonHealthcare Pavillion
    Norton Medical Plaza II
    Norton Medical Plaza West
    Old Brownsboro Crossing
    Breast Cancer
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    James Graham Brown Cancer Center at University of Louisville
    Louisville, Kentucky 40202
    Lung Cancer
    Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
    University of Louisville
    Louisville, Kentucky 40202
    High Risk Stage III Melanoma
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    Kentucky Lung Clinic

    Trial Locations
    Kentucky Lung Clinic
    Univ. Of Kentucky Dept. Of Surgery
    Venous Thrombosis